Medical Xpress
The U.S. Food and Drug Administration has approved AbbVie’s Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson’s disease (PD…
Read More
FDA approves Vyalev for advanced Parkinson’s disease
The U.S. Food and Drug Administration has approved AbbVie’s Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson’s disease (PD…